Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A custom microarray platform for analysis of microRNA gene expression.

J Michael Thomson1, Joel Parker, Charles M Perou

  • 1Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

Nature Methods
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Integrated Multiomic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer.

Cancer research·2026
Same author

Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers.

bioRxiv : the preprint server for biology·2026
Same author

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO).

Nature communications·2026
Same author

MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9<sup>+</sup> monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.

bioRxiv : the preprint server for biology·2026
Same author

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Nature communications·2026

Researchers developed dual-channel microarrays to quantify microRNA expression. This technology reveals distinct expression patterns in mouse tissues and embryos, advancing the study of these regulatory RNA molecules.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are short, noncoding RNA molecules regulating gene expression post-transcriptionally.
  • Hundreds of miRNA genes exist across diverse species, including mammals.
  • miRNAs play roles in development, cell growth, and apoptosis.

Purpose of the Study:

  • To address the lack of quantitative expression profiling methods for microRNAs.
  • To develop and utilize novel microarray technology for comprehensive miRNA analysis.

Main Methods:

  • Design and implementation of dual-channel microarrays.
  • Monitoring expression levels of 124 mammalian microRNAs.
  • Analysis of miRNA expression in adult mouse tissues, embryonic stem cells, and staged embryos.

Related Experiment Videos

Main Results:

  • Distinct microRNA expression patterns were observed in adult mouse tissues and embryonic stem cells.
  • Temporal regulation of numerous microRNAs, including the let-7 family, was identified in staged embryos.
  • The developed microarray technology provides a quantitative approach to miRNA profiling.

Conclusions:

  • Dual-channel microarray technology enables comprehensive investigation of microRNA expression.
  • This advancement furthers the understanding of microRNA function and regulation in mammals.
  • MicroRNA expression is dynamically regulated during embryonic development.